Bristol-Myers Squibb 3Q Revenues: $4.9 billion (+21%) 3Q Earnings: $1.2 billion (+66%) YTD Revenues: $12.9 billion (+16%) YTD Earnings: $3.6 billion (+98%) Comments: U.S. revenues increased 36% to $2.8 billion in the quarter and international revenues increased 5%.  Opdivo sales were $920 million in the quarter, up from $305 million 3Q15.Eliquis sales were up 90% to $84 million; Yervoy sales were up 19% to $285 million; Orencia sales grew 18% to $572 million; and Sprycel sales wer...